This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Buckway, C. K. Articles by Rosenfeld, R. G. Search for Related Content PubMed PubMed Citation Articles by Buckway, C. K. Articles by Rosenfeld, R. G.

The IGF-I Generation Test Revisited: A Marker of GH Sensitivity

Department of Pediatrics, Oregon Health Sciences University (C.K.B., K.L.P., R.G.R.), Portland, Oregon 97201; Institute of Endocrinology, Metabolism, and Reproduction (J.G.-A.), Quito, Ecuador; and Queen Mary’s Hospital for Children (C.P.B.), Carshalton, United Kingdom 5M5 1AA

Address all correspondence and requests for reprints to: Caroline K. Buckway, M.D., c/o Ron G. Rosenfeld, M.D., Department of Pediatrics, Oregon Health Sciences University, 707 SW Gaines Road, CDRC-P, Portland, Oregon 97201. E-mail: cbuckway{at}yahoo.com

Abstract

IGF-I generation tests were developed over 20 yr ago and are currently used in differentiating GH insensitivity (GHI) from other disorders characterized by low serum IGF-I. Nevertheless, generation tests have never been adequately characterized, and insufficient normative data are available.

One hundred and ninety-eight subjects [including normal subjects; subjects with GHI, GH deficiency (GHD), and idiopathic short stature (ISS); and heterozygotes for the E180 splice GH receptor mutation] were randomized to self-administration of either a high (0.05 mg/kg·d) or a low (0.025 mg/kg·d) dose of GH for 7 d. After a 2-wk washout period, they received the alternate dose. Samples were collected on d 1, 5, and 8 of each treatment period.

In normal individuals, IGF-I generation was GH dependent at all ages, and little advantage was observed in using the higher dose of GH or extending beyond the d 5 sample. Some GHD patients had IGF-I levels, both baseline and stimulated, that overlapped levels in the verified GHI patients. Subjects heterozygous for the E180 GH receptor splice mutation did not show a decreased responsiveness to GH. ISS patients had low-normal IGF-I levels that did not stimulate beyond the baseline normative ranges for age. These data provide the first large scale effort to provide preliminary normative IGF generation data and evaluate the GH sensitivity of patients with GHI, GHD, and ISS.

This article has been cited by other articles:

				T Edouard, S Grunenwald, I Gennero, J P Salles, and M Tauber Prevalence of IGF1 deficiency in prepubertal children with isolated short stature Eur. J. Endocrinol., July 1, 2009; 161(1): 43 - 50. [Abstract] [Full Text] [PDF]

				E. C. Walvoord, A. de la Pena, S. Park, B. Silverman, L. Cuttler, S. R. Rose, G. Cutler, S. Drop, and J. J. Chipman Inhaled Growth Hormone (GH) Compared with Subcutaneous GH in Children with GH Deficiency: Pharmacokinetics, Pharmacodynamics, and Safety J. Clin. Endocrinol. Metab., June 1, 2009; 94(6): 2052 - 2059. [Abstract] [Full Text] [PDF]

				F. Peter, C. Savoy, H.-J. Ji, M. Juhasz, M. Bidlingmaier, and P. Saenger Pharmacokinetic and pharmacodynamic profile of a new sustained-release GH formulation, LB03002, in children with GH deficiency Eur. J. Endocrinol., March 1, 2009; 160(3): 349 - 355. [Abstract] [Full Text] [PDF]

				P. F. Collett-Solberg, M. Misra, and on behalf of the Drug and Therapeutics Committee o The Role of Recombinant Human Insulin-Like Growth Factor-I in Treating Children with Short Stature J. Clin. Endocrinol. Metab., January 1, 2008; 93(1): 10 - 18. [Abstract] [Full Text] [PDF]

				V. Petkovic, A. Besson, M. Thevis, D. Lochmatter, A. Eble, C. E. Fluck, and P. E. Mullis Evaluation of the Biological Activity of a Growth Hormone (GH) Mutant (R77C) and Its Impact on GH Responsiveness and Stature J. Clin. Endocrinol. Metab., August 1, 2007; 92(8): 2893 - 2901. [Abstract] [Full Text] [PDF]

				R. G Rosenfeld Pharmacogenomics and pharmacoproteomics in the evaluation and management of short stature Eur. J. Endocrinol., August 1, 2007; 157(suppl_1): S27 - S31. [Abstract] [Full Text] [PDF]

				V. Petkovic, M. Thevis, D. Lochmatter, A. Besson, A. Eble, C. E Fluck, and P. E Mullis GH mutant (R77C) in a pedigree presenting with the delay of growth and pubertal development: structural analysis of the mutant and evaluation of the biological activity Eur. J. Endocrinol., August 1, 2007; 157(suppl_1): S67 - S74. [Abstract] [Full Text] [PDF]

				L. L. Levitsky Defining the Role of IGF-I Therapy for Short Children J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 813 - 814. [Full Text] [PDF]

				N. Bouhours-Nouet, F. Gatelais, F. Boux de Casson, S. Rouleau, and R. Coutant The Insulin-Like Growth Factor-I Response to Growth Hormone Is Increased in Prepubertal Children with Obesity and Tall Stature J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 629 - 635. [Abstract] [Full Text] [PDF]

				M. Rauchenzauner, A. Schmid, P. Heinz-Erian, K. Kapelari, G. Falkensammer, A. Griesmacher, G. Finkenstedt, and W. Hogler Sex- and Age-Specific Reference Curves for Serum Markers of Bone Turnover in Healthy Children from 2 Months to 18 Years J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 443 - 449. [Abstract] [Full Text] [PDF]

				E. O. Reiter, D. A. Price, P. Wilton, K. Albertsson-Wikland, and M. B. Ranke Effect of Growth Hormone (GH) Treatment on the Near-Final Height of 1258 Patients with Idiopathic GH Deficiency: Analysis of a Large International Database J. Clin. Endocrinol. Metab., June 1, 2006; 91(6): 2047 - 2054. [Abstract] [Full Text] [PDF]

				V. Hwa, G. Haeusler, K. L. Pratt, B. M. Little, H. Frisch, D. Koller, and R. G. Rosenfeld Total Absence of Functional Acid Labile Subunit, Resulting in Severe Insulin-Like Growth Factor Deficiency and Moderate Growth Failure J. Clin. Endocrinol. Metab., May 1, 2006; 91(5): 1826 - 1831. [Abstract] [Full Text] [PDF]

				V. Hwa, B. Little, P. Adiyaman, E. M. Kofoed, K. L. Pratt, G. Ocal, M. Berberoglu, and R. G. Rosenfeld Severe Growth Hormone Insensitivity Resulting from Total Absence of Signal Transducer and Activator of Transcription 5b J. Clin. Endocrinol. Metab., July 1, 2005; 90(7): 4260 - 4266. [Abstract] [Full Text] [PDF]

				A. Besson, S. Salemi, J. Deladoey, J.-M. Vuissoz, A. Eble, M. Bidlingmaier, S. Burgi, U. Honegger, C. Fluck, and P. E. Mullis Short Stature Caused by a Biologically Inactive Mutant Growth Hormone (GH-C53S) J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2493 - 2499. [Abstract] [Full Text] [PDF]

				V. Popovic, D. Miljic, S. Pekic, P. Pesko, M. Djurovic, M. Doknic, S. Damjanovic, D. Micic, G. Cvijovic, J. Glodic, et al. Low Plasma Ghrelin Level in Gastrectomized Patients Is Accompanied by Enhanced Sensitivity to the Ghrelin-Induced Growth Hormone Release J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2187 - 2191. [Abstract] [Full Text] [PDF]

				P. E Mullis Genetic control of growth Eur. J. Endocrinol., January 1, 2005; 152(1): 11 - 31. [Abstract] [Full Text] [PDF]

				R. Coutant, F. B. de Casson, S. Rouleau, O. Douay, E. Mathieu, F. Gatelais, N. Bouhours-Nouet, C. Voinot, M. Audran, and J. M. Limal Divergent Effect of Endogenous and Exogenous Sex Steroids on the Insulin-Like Growth Factor I Response to Growth Hormone in Short Normal Adolescents J. Clin. Endocrinol. Metab., December 1, 2004; 89(12): 6185 - 6192. [Abstract] [Full Text] [PDF]

				R. G. Rosenfeld and V. Hwa Toward a Molecular Basis for Idiopathic Short Stature J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1066 - 1067. [Full Text] [PDF]

				H. M. Domene, S. V. Bengolea, A. S. Martinez, M. G. Ropelato, P. Pennisi, P. Scaglia, J. J. Heinrich, and H. G. Jasper Deficiency of the Circulating Insulin-like Growth Factor System Associated with Inactivation of the Acid-Labile Subunit Gene N. Engl. J. Med., February 5, 2004; 350(6): 570 - 577. [Full Text] [PDF]

				C. A. Lissett and S. M. Shalet The Impact of Dose and Route of Estrogen Administration on the Somatotropic Axis in Normal Women J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4668 - 4672. [Abstract] [Full Text] [PDF]

				E. M. Kofoed, V. Hwa, B. Little, K. A. Woods, C. K. Buckway, J. Tsubaki, K. L. Pratt, L. Bezrodnik, H. Jasper, A. Tepper, et al. Growth Hormone Insensitivity Associated with a STAT5b Mutation N. Engl. J. Med., September 18, 2003; 349(12): 1139 - 1147. [Full Text] [PDF]

				R. Marino, E. Chaler, M. Warman, M. Ciaccio, E. Berensztein, M. A. Rivarola, and A. Belgorosky The Serum Growth Hormone (GH) Response to Provocative Tests Is Dependent on Type of Assay in Autosomal Dominant Isolated GH Deficiency because of an ARG183HIS (R183H) GH-I Gene Mutation Clin. Chem., June 1, 2003; 49(6): 1002 - 1005. [Full Text] [PDF]

				A. M. Haqq, D. D. Stadler, R. H. Jackson, R. G. Rosenfeld, J. Q. Purnell, and S. H. LaFranchi Effects of Growth Hormone on Pulmonary Function, Sleep Quality, Behavior, Cognition, Growth Velocity, Body Composition, and Resting Energy Expenditure in Prader-Willi Syndrome J. Clin. Endocrinol. Metab., May 1, 2003; 88(5): 2206 - 2212. [Abstract] [Full Text] [PDF]

				C. K. Buckway, K. A. Selva, K. L. Pratt, E. Tjoeng, J. Guevara-Aguirre, and R. G. Rosenfeld Insulin-Like Growth Factor Binding Protein-3 Generation as a Measure of GH Sensitivity J. Clin. Endocrinol. Metab., October 1, 2002; 87(10): 4754 - 4765. [Abstract] [Full Text] [PDF]

				P. A. Gruppuso The Clinical Laboratory Evaluation of GH Responsiveness J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 466 - 468. [Full Text] [PDF]

				A. A. Jorge, S. C. Souza, I. J. Arnhold, and B. B. Mendonca Poor Reproducibility of IGF-I and IGF Binding Protein-3 Generation Test in Children with Short Stature and Normal Coding Region of the GH Receptor Gene J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 469 - 472. [Abstract] [Full Text] [PDF]

				P. Marzullo, C. Buckway, K. L. Pratt, A. Colao, J. Guevara-Aguirre, and R. G. Rosenfeld Leptin Concentrations in GH Deficiency: The Effect of GH Insensitivity J. Clin. Endocrinol. Metab., February 1, 2002; 87(2): 540 - 545. [Abstract] [Full Text] [PDF]